Individual GiftsCorporate Support & GivingThe Forward FundNamed Funds & AwardsThe Checkpoints: SITC's House BandSITC Merchandise

Individual Gifts

Stocks and Securities

(Took this from Fidelity's website - revise) Make a larger impact by donating long-term appreciated securities, including stock, bonds, and mutual funds, directly to charity. Compared with donating cash, or selling your appreciated securities and contributing the after-tax proceeds, you may potentially increase your gift and tax donation. 

Please discuss any stock contributions with your financial advisor. 

Estate and Planned Gifts

Join SITC’s Legacy Society

SITC’s Legacy Society celebrates our most dedicated and generous supporters who invest in supporting our research and improving patient health and outcomes. By making a planned gift to the SITC Legacy Society, you will help SITC continue to invest in the future of the field. People of all ages can give to SITC while still providing for their families and preserving their retirement assets.
 
Ways to Make Deferred Gift
 
Gifts from a Will or Trust
Simply name SITC as a beneficiary in your will or trust.*  You can use simple language such as:

"I give, devise, and bequeath $_____ (or _____%) to the Society for Immunotherapy of Cancer 555 east Wells Street, Suite 1100, Milwaukee, WI  53202."     
(*Your personal tax advisor or family attorney can assist.)

Gifts by Beneficiary Designations
Name SITC as the beneficiary of a retirement plan, financial account or annuity. You will continue to benefit from these assets during your lifetime.

Gifts of Life Insurance
Gift unused life insurance policies to SITC and take an immediate tax deduction. You may also name SITC as a beneficiary of your policy.

To explore any of these gifts opportunities, please contact development@sitcancer.org or (414) 271-2456.

The information provided above is not intended to be legal or tax advice. We recommend that you contact a qualified attorney or financial advisor to ensure your wishes for family and our organization are properly documented

Honor and Memorial Gifts

A memorial or honor gift is a meaningful way to commemorate a loved one, celebrate a special occasion, or express gratitude and admiration for someone significant in your life.

You can make a memorial or honor gift through our online donation portal, or we are happy to provide guidance on available options. We want to ensure that your gift is used in a way that best honors the individual's legacy.

By giving a memorial or honor gift, you celebrate a life well-lived and ensure that their spirit continues to inspire and make a difference in the world.

SITC Merchandise

 

Corporate Support and Giving Opportunities

Corporate Membership

The Society for Immunotherapy of Cancer (SITC) offers a corporate membership program. Designed to foster communication between industry partners and SITC leaders, organizations from all touchpoints within industry, including pharmaceutical, technology and investments firms, are eligible for a SITC corporate membership.

A SITC corporate membership provides organizations in the field of cancer immunotherapy and cancer research a forum to address common issues impacting the field with the goal of improving cancer patient outcomes.

Benefits of a SITC corporate membership program include:

  • Industry Roundtable: SITC engages industry leaders to address key issues and hurdles in the field. SITC corporate member representatives participate in the meetings organized around key issues that affect their interests
  • Private meeting with SITC leadership: SITC corporate members receive exclusive access to SITC leadership through a private meeting each year at a location and time amenable to both parties

Dues for SITC corporate memberships are determined by the size of the organization. The dues structure is as follows:

  • Small (less than or equal to 250 employees) = $10,000 annual dues
  • Medium (251-1,000 employees) = $20,000 annual dues
  • Large (1,001-5,000 employees) = $35,000 annual dues
  • Mega (greater than 5,000 employees) = $50,000 annual dues

SITC is proud to be a broker of new relationships among the individuals leading the next generation of cancer immunotherapy research.

To learn more about how your organization can benefit from becoming a SITC corporate member, contact the SITC Development Team at (414) 271-2456 or development@sitcancer.org.

Educational Grants

Show your commitment to cancer immunotherapy education by providing an educational grant for any of SITC’s programs, including the Annual Meeting and Pre-Conference Programs, Advances in Cancer Immunotherapy™ regional programs, or other SITC initiatives. Contact the Development Team at (414) 271-2456 or development@sitcancer.org to discuss programs and opportunities.

SITC and our accrediting partners jointly provide many of SITC’s live educational programs. As a result, these activities must abide by the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education in the development of educational activities.

Organizations that support an educational session cannot be involved in the development or execution of the presentations. This includes selecting the content, faculty and format of the session.

Sponsorship and Advertising

SITC offers a number of ways to promote your product or service throughout the year and at various programs. SITC 2022 will be presented as a hybrid meeting, which means we have innovative in-person and virtual solutions to meet your marketing and branding needs.

Contact development@sitcancer.org or (414) 271-2456 for more information and to discuss customization options.

Support Opportunities Guide

Contact the SITC Development Team at (414) 271-2456 or development@sitcancer.org to request a copy of the Support Opportunities Guide and discuss exciting opportunities!

(Include link to the guide - or flipbook)

Exhibitor Prospectus

The 2022 Exhibitor Prospectus will be released in March. Contact mlaue@sitcancer.org with any questions or to be added to the 2022 contact list!

Named Funds and Awards

Early Career Scientist Awards

To promote growth and achievement amongst young investigators in the field of cancer biologics and to recognize excellence in the oral abstract and poster presentations submitted to the Society for Immunotherapy of Cancer's (SITC) Annual Meeting, SITC offers the Young Investigator Awards.

For the SITC Presidential Travel Awards, four abstracts submitted in any category and authored by young investigators were selected for oral presentation during the Presidential Session of the SITC Annual Meeting. Those presenting authors not selected for the SITC Presidential Award will receive a SITC Presidential Travel Award in recognition of their achievement.

SITC Travel Awards are given to a select number of young investigators who submitted an abstract for the SITC Annual Meeting. The abstracts are judged by a committee of SITC leadership and SITC Annual Meeting organizers.

Support Early Career Scientists

Richard V. Smalley Memorial Award and Lectureship

Dr. Philip Greenberg
Dr. Philip Greenberg accepts the 2018 SITC Smalley Memorial Award at the 33rd Annual Meeting.

In memory of past Society for Immunotherapy of Cancer (SITC) president and charter member, Dr. Richard V. Smalley, SITC is proud to present the Richard V. Smalley Memorial Award and Lectureship annually to a recognizable clinician/scientist and luminary in the field who has significantly contributed to the advancement of cancer immunotherapy research.

Established in 2005, the SITC Smalley Award is the society’s most prestigious award and serves to honor those who have been pioneers in their work and made a notable impact worthy of high regard and recognition by their peers. As a part of the award, the honoree serves as a primary keynote presenter at the society's Annual Meeting, delivering a lecture on his/her research. The award is accompanied by an honorarium of $5,000.

Support Early Career Scientists

Steven A. Rosenberg Scholars Award

Steven A. RosenbergThe SITC Steven A. Rosenberg Scholars Award Fund was established in honor of Dr. Rosenberg and his many contributions to the field of immuno-oncology.

Your donation to this fund will support early career investigators, who are emerging leaders in immuno-oncology, focused on a novel approach to advancing the field of immunology and cancer immunotherapy. 

SITC is also seeking nominations for award recipients. The award supports early career scientists focused on tackling challenges that face the field of immunology and cancer immunotherapy.

Learn More

Technology Awards

sitc_log_color.pngEstablished in 2020, the Society for Immunotherapy of Cancer (SITC) Technology Awards serve as recognition to early career investigators who are poised to transform the immuno-oncology landscape through their research. The recipient(s) of this research award receive access to technologies and tools provided by sponsoring companies. 

Review Winners

Martin "Mac" Cheever Travel Award Fund

Award Background

Established in 2022 in loving memory of Dr. Martin "Mac" Cheever, this fund recognizes his many contributions to the field of cancer immunotherapy by providing travel awards to deserving early career investigators pursuing excellence in clinical trial design.

Dr. Cheever, a champion of immunotherapy, established the Cancer Immunotherapy Trials Network (CITN) and was passionate about excellence in clinical trial design. This fund honors his memory by carrying forward his drive for sound design in clinical trial development and a commitment to inspiring the next generation of translational scientists.

Award Criteria

Each year, SITC will identify the best and brightest in the field to continue Dr. Cheever’s passion for improving immunotherapy protocols through the Martin “Mac” Cheever Excellence in Clinical Trial Design - Travel Award.  This select group of deserving early career investigators will look to advance cancer immunotherapy through simple and elegant clinical trial design.

The awardee will be selected from the participants in SITC’s Clinical Immuno-Oncology Network (SCION) Workshop as having the most simple and elegant protocol at the close of the intensive and selective workshop. If the SCION workshop is not held in any given year, the awardee will be selected from the early phase clinical trial abstracts submitted to the SITC Annual Meeting.

The awardee will receive flight, hotel, and meal reimbursement to fully support their travel to the SITC Annual Meeting in the same year that they are selected as the recipient of the award.

Award Selection

The Mac Cheever Excellence in Clinical Trial Design -Travel Award Committee, will serve as the selection committee and use SCION’s Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet as the basis to score and rank the applicant’s protocols. (Based on the International Committee for Harmonization’s (ICH) synopsis worksheet, SCION’s form has been adapted slightly to fit the specific needs of the program.) The awardee will be notified within one week of selection.

Awardees will be notified by the Committee Chair and invited to attend SITC’s Annual Meeting as a Cheever Travel Awardee. The recipients will formally accept the award during the SITC Annual Meeting Award Ceremony.

Contribute to the Mac Cheever Fund

Honor Dr. Cheever's legacy with a gift to the Mac Cheever Travel Award Fund. Donate online or contact Rebecca Gregory at (414) 271-2456 or rgregory@sitcancer.org. 

Review Winners

SITC Sparkathon

Support the SITC Sparkathon Today

Launched in 2017, the SITC Sparkathon program aims to bring together young investigators of various backgrounds, degrees and professional experiences to collaboratively solve hurdles facing the field of cancer immunotherapy over a one-year period.

You can help early career scientists tackle the hurdles facing cancer immunotherapy by supporting this innovative program.

Be the spark by making a gift to the Forward Fund. Give today and your gift will be matched by an anonymous donor to double your impact!* You can contribute to making cancer immunotherapy a standard of care and the word “cure” a reality for patients everywhere.

Match applies to new and increased gifts through Dec. 31, 2024
As a 501(c)(3) organization, donations made to SITC are tax deductible as a charitable contribution to the extent allowed by law.

Support the Sparkathon

Forward Fund

About the Forward Fund

The future of cancer immunotherapy is rooted in research and education, primarily by early career scientists. The Forward Fund was established by the Society for Immunotherapy of Cancer (SITC) in 2012 to stimulate the future of science, development and application of cancer immunology and immunotherapy through financially supporting its education and research.

Ultimately, the Forward Fund (Donate online here) endeavors to provide grants and financially support activities and initiatives that:

  • Help attract the brightest young minds in cancer and/or immunology research to the cancer immunotherapy domain
  • Inform those outside of the cancer immunotherapy field about the huge promise of this modality. Cancer immunotherapy offers the potential to create long-term remissions and/or prolonged survival for people suffering from advanced cancer of a wide variety of types and educate clinical
  • Educate clinical oncologists regarding the application and potential benefits of this treatment modality

Forward Fund Strategy

  • Provide grants to promising young post-doctoral researchers to help them complete cancer immunotherapy research projects and bridge the gap between their post-doctoral studies and academic or industry appointments
  • Encourage more young scientists to enter the field of cancer immunotherapy research at academic, governmental or industry institutions
  • Interact with patients and advocacy networks to address their specific needs for education and resources on cancer immunotherapy as an increasingly promising treatment option
  • Develop policies on best practices in cancer immunotherapy clinical trials, assessment of relevant immunologic biomarkers, and clinical management
  • Educate clinical oncologists and laboratory scientists on the complex state of the art principles underlying cancer immunology and their applications to the clinic
  • Expand international collaborations among cancer immunotherapy researchers to identify and overcome major barriers in the field worldwide